Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure Yahoo FinanceEli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF Yahoo FinanceSUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity TCTMDEli Lilly's weight-loss drug helps nearly 99% of patients remain diabetes-free ReutersOzempic could prevent diabetes.